Better treatment outcomes with aripiprazole long-acting injection in community and incarcerated patients with serious mental illness
This study of 34 community and 21 incarcerated patients revealed significant demographic and medical history differences. Both groups experienced reduced hospitalizations and improvements in CGI-S scores and quality of life following aripiprazole LAI administration. Community patients showed a greater reduction in hospitalizations, while clinical and quality-of-life improvements were comparable across groups.
Authors
- Ioannis Mouzas
- Henrik Walter (ORCID: https://orcid.org/0000-0002-9403-6121)
- E. I. Koiliari
- Emmanouil Pasparakis
- Georgios Alevizopoulos (ORCID: https://orcid.org/0000-0001-5573-9476)
- Otto Lesch
Institutions
- University of Crete (GR)
- National and Kapodistrian University of Athens (GR)
- Agios Pavlos General Hospital (GR)
- Hospital Agioi Anargyroi (GR)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3389/fpsyt.2025.1499400
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agios Pharmaceuticals